OBESITY AND HYPERTENSION

被引：66

作者：

HSUEH, WA

BUCHANAN, TA

机构：

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 1994年 / 23卷 / 02期

关键词：

D O I：

10.1016/S0889-8529(18)30105-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：405 / 427

页数：23

共 161 条

[61] OBESITY-INDUCED HYPERTENSION - RENAL-FUNCTION AND SYSTEMIC HEMODYNAMICS [J].

HALL, JE ;

BRANDS, MW ;

DIXON, WN ;

SMITH, MJ .

HYPERTENSION, 1993, 22 (03) :292-299

[62]

HERMANN LS, 1979, DIABETES METAB, V5, P233

[63] TREATMENT OF INSULIN-RESISTANT MICE WITH THE ORAL ANTIDIABETIC AGENT PIOGLITAZONE - EVALUATION OF LIVER GLUT2 AND PHOSPHOENOLPYRUVATE CARBOXYKINASE EXPRESSION [J].

HOFMANN, CA ;

EDWARDS, CW ;

HILLMAN, RM ;

COLCA, JR .

ENDOCRINOLOGY, 1992, 130 (02) :735-740

[64] NEW ORAL THIAZOLIDINEDIONE ANTIDIABETIC AGENTS ACT AS INSULIN SENSITIZERS [J].

HOFMANN, CA ;

COLCA, JR .

DIABETES CARE, 1992, 15 (08) :1075-1078

[65] ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE [J].

HOTAMISLIGIL, GS ;

SHARGILL, NS ;

SPIEGELMAN, BM .

SCIENCE, 1993, 259 (5091) :87-91

[66]

HSUEH WA, 1992, YB NEPHROLOGY, P117

[67] FRUCTOSE-INDUCED INSULIN RESISTANCE AND HYPERTENSION IN RATS [J].

HWANG, IS ;

HO, H ;

HOFFMAN, BB ;

REAVEN, GM .

HYPERTENSION, 1987, 10 (05) :512-516

[68] EFFECT OF NEW ORAL ANTIDIABETIC AGENT CS-045 ON GLUCOSE-TOLERANCE AND INSULIN-SECRETION IN PATIENTS WITH NIDDM [J].

IWAMOTO, Y ;

KUZUYA, T ;

MATSUDA, A ;

AWATA, T ;

KUMAKURA, S ;

INOOKA, G ;

SHIRAISHI, I .

DIABETES CARE, 1991, 14 (11) :1083-1086

[69] LONG-TERM METABOLIC EFFECTS OF SPIRONOLACTONE AND THIAZIDES COMBINED WITH POTASSIUM-SPARING AGENTS FOR TREATMENT OF ESSENTIAL-HYPERTENSION [J].

JEUNEMAITRE, X ;

CHARRU, A ;

CHATELLIER, G ;

DEGOULET, P ;

JULIEN, J ;

PLOUIN, PF ;

CORVOL, P ;

MENARD, J .

AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (16) :1072-1077

[70]

JULIUS S, 1990, JAMA-J AM MED ASSOC, V264, P354

← 2 3 4 5 6 7 8 9 10 11 →